The ligand-induced differentiation involved the AML stem/progenitor cells and was characterized by increased levels of CD11b, CD14 and CD15, as well as morphological signs of differentiation (i.e., altered nuclear morphology) and decreased AML cell proliferation. This evidence concerns the gene CD14 and acute myeloid leukemia.